Ilijan Tomaš

Prof. Dr. Ilijan Tomaš

orcid

Research Focus & Metrics

Academic Career Length

25Years (2002-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
13 May 2024 in Diagnostics
Verified
Journal Article
Open access
PDF file
MFMirela Frančina
Mirela Frančina
MMMislav Mikuš
Mislav Mikuš
Marin MamićMarin Mamić
Marin Mamić
TJTihomir Jovanović
Tihomir Jovanović
MĆMario Ćorić
Mario Ćorić
ITIlijan Tomaš
Ilijan Tomaš
Background: This study aims to evaluate PD-L1 expression in colorectal carcinomas (CRCs) by using the tumor proportion score (TPS) and the combined positive score (CPS), and to investigate whether there is a correlation with clinicopathologic features. Methods: A cross-sectional study was conducted that included samples from patients with colorectal adenocarcinoma treated with colon resection and rectal resection after neoadjuvant radio- and chemotherapy at the Department of Abdominal Surgery at Požega Hospital in the period from 2017 to 2022. The study included 102 tumor tissue samples from patients after resection and the pathohistological diagnosis of adenocarcinoma. Results: In our study, the PD-L1 positivity rate after the TPS was 42 (41%) samples, and after the CPS, 97 (95%) of them (p < 0.001). The positive expression of PD-L1 in tumor cells using the TPS method showed a statistically significant association with adenocarcinoma (TPS ≥ 10–50% and ≥50%). There were significantly more that were moderately differentiated, with TPS ≥ 50%, and those poorly differentiated had values ≥ 10–50%. There were significantly more patients with a status of more than one positive lymph node with TPS values ≥ 10–50%. Patients without metastases in the lymph nodes are significantly more likely to have CPS values > 50%, compared with other lymph node statuses. Conclusions: These results suggest that the total number of PD-L1-expressing cells, including tumor and immune cells, is a more sensitive biomarker than the number of PD-L1-expressing tumor cells alone in CRC.

1 January 2007 in Radiology and Oncology
Verified
Journal Article
Open access
PDF file
MKMladen Kasabasic
Mladen Kasabasic
DFDario Faj
Dario Faj
NBNenad Belaj
Nenad Belaj
ZFZlatan Faj
Zlatan Faj
ITIlijan Tomaš
Ilijan Tomaš
Background. Patient positioning errors in pelvic radiotherapy at Department of Oncology and Radiotherapy in Osijek are explored in order to establish the offline setup correction protocol and determine the safety margins. Material and methods. Film portal imaging is used during the whole treatment in order to find patient positioning errors. Eleven patients are included in the study and 420 images are analyzed. Setup errors are found by measuring distances between the center of the field and bony landmarks. Systematic and random errors are analyzed. Results. Safety margins that should be employed at our department are 11 mm, 13 mm and 14 mm in mediolateral, craniocaudal and anteroposterior direction, respectively. Time trend is found only in an aged, obese patient with a hip problem. No action level offline setup protocol was employed by taking and averaging first four images in mediolateral and craniocaudal and 5 images in anteroposterior direction. Conclusions. Since time trend is found only in a patient who was hard to position because of his age, obesity and the hip problem, we decided that such patients are to be positioned without a bellyboard and in supine position. Time trends are not found in all of the other patients so we employed the offline setup error protocol by averaging setup errors from the first few consecutive images. Safety margins that will ensure 90% probability of depositing at least 95% of the prescribed dose in the target are calculated. Safety margins and number of images that should be taken showed that the most inaccurate positioning was in the anteroposterior direction.

1 September 2018 in Lijecnicki Vjesnik
Verified
Journal Article
Open access
EVEduard Vrdoljak
Eduard Vrdoljak
SPStjepko Pleština
Stjepko Pleština
TOTomislav Omrčen
Tomislav Omrčen
AJAntonio Juretić
Antonio Juretić
IBIngrid Belac-Lovasić
Ingrid Belac-Lovasić
KOKlinika Za Onkologiju
Klinika Za Onkologiju

22 October 2025 in Vaccines
Verified
Journal Article
Open access
PDF file
IŠIvana Kotromanović Šimić
Ivana Kotromanović Šimić
DKDarko Kotromanović
Darko Kotromanović
Nika Lovrincevic PavlovicNika Lovrincevic Pavlovic
Nika Lovrincevic Pavlovic
JKJelena Kovačević
Jelena Kovačević
MOMarija Olujić
Marija Olujić
Maja MiskulinMaja Miskulin
Maja Miskulin
Background/Objectives: The Human Papillomavirus (HPV) is one of the most common causes of STIs, posing a significant public health problem. Today, the transmission of HPV can be very effectively prevented, making it important to vaccinate the target population at a young age. The aim of this study was to examine the attitudes and beliefs of parents regarding the HPV vaccine and the HPV vaccination of their child. Methods: This cross-sectional study was conducted in Osijek, Croatia, from June 2021 to September 2022 via a self-administered questionnaire and included 215 respondents. Results: The results showed that respondents who would vaccinate their child were significantly more likely to be those who work in the healthcare field, who had heard of the term HPV, who had sought information about the HPV vaccine on their own, and who had received information about vaccination from school doctors. The attitude towards vaccination was more negative among respondents who did not intend to vaccinate their child. In predicting the decision not to vaccinate one’s child against HPV, bivariate logistic regression revealed that the probability of non-vaccination increases with working outside the field of healthcare (OR = 4.61) and a negative attitude towards vaccination (OR = 1.46), while the probability of non-vaccination decreases if information was received from a school doctor (OR = 0.46). Furthermore, multivariate logistic regression showed that there is a significant model in predicting non-vaccination against HPV, consisting of two predictors: working outside the healthcare field (OR = 8.15) and a negative attitude towards vaccination (OR = 1.49). Conclusions: Given that parents are responsible for making the decision about HPV vaccination, it is necessary to invest additional efforts in educating them about the importance of preventing HPV infections and the benefits of HPV vaccination itself.

23 August 2023 in Pharmaceutics
Verified
Journal Article
Open access
PDF file
JTJosipa Glavas Tahtler
Josipa Glavas Tahtler
DDDajana Djapic
Dajana Djapic
MNMarina Neferanovic
Marina Neferanovic
JMJelena Miletic
Jelena Miletic
MMMarta Milosevic
Marta Milosevic
SKSlavica Kvolik
Slavica Kvolik
Breast cancer is the most common malignant disease in women. Preclinical studies have confirmed that the local anesthetic levobupivacaine has a cytotoxic effect on breast cancer cells. We examined whether postoperative wound infiltration with levobupivacaine influences survival in 120 patients who were operated on for breast cancer and underwent quadrantectomy or mastectomy with axillary lymph node dissection. Groups with continuous levobupivacaine wound infiltration, bolus wound infiltration, and diclofenac analgesia were compared. Long-term outcomes examined were quality of life, shoulder disability, and hand grip strength (HGS) after one year and survival after 5 and 10 years. Groups that had infiltration analgesia had better shoulder function compared to diclofenac after one year. The levobupivacaine PCA group had the best-preserved HGS after 1 year (P = 0.022). The most significant predictor of the 5-year outcome was HGS (P = 0.03). Survival at 10 years was 85%, 92%, and 77% in the diclofenac, levobupivacaine bolus, and levobupivacaine PCA groups (ns. P = 0.36). The extent of the disease at the time of surgery is the most important predictor of long-term survival (P = 0.03). A larger prospective clinical study could better confirm the effect of levobupivacaine wound infiltration on outcomes after breast cancer surgery observed in this pilot study—trial number NCT05829707.

3 January 2026 in Cancers
Verified
Journal Article
Open access
PDF file
BTBojan Trogrlić
Bojan Trogrlić
ABAna Bednjanic
Ana Bednjanic
BKBorna Kovacic
Borna Kovacic
ZPZrinka Požgain
Zrinka Požgain
DMDario Mandic
Dario Mandic
ITIlijan Tomaš
Ilijan Tomaš
Background/Objectives: There is an increasing need for methods that provide improved insight into the molecular basis of colorectal cancer (CRC) and thus a better understanding of its morphological heterogeneity. The objectives of this study were to evaluate the use of imaging mass spectrometry (IMS) to examine tumor margins and gain insight into the molecular heterogeneity of CRC. Methods: An observational study involving 10 cases was conducted. Native tissue samples were collected during the subject’s surgery, and consecutively taken tissue sections were immediately prepared for light microscopic and IMS analysis. IMS was performed across the 200–1000 Da mass range, divided into four sub-ranges, using matrix-assisted laser desorption/ionization time-of-flight mass spectrometry (MALDI TOF MS) in both negative and positive modes of ionization. For tumor margin and tissue heterogeneity assessment, image segmentation was used. Segmented MS images were analyzed against the respective light microscopy images of hematoxylin-eosin-stained tissue sections. Results: Quantitative analysis of the sample collection indicated that IMS enabled correct recognition of tumor margin in the 800–1000 Da range using binary segmentation. Denary image segmentation depicted tissue heterogeneity in greater detail. The strongest m/z signals specific to tumor, peritumor, and margins were identified and tentatively annotated: aside from dCTP, all other compounds were patient-specific, indicating interindividual variations in the molecular composition of CRC. Conclusions: IMS provides new insights into the morphological and biochemical properties of CRC: binary segmented MS images can clearly depict the tumor margin in the 800–1000 Da range, while denary segmented MS images depict intra- and inter-individual molecular heterogeneity of CRC.